Dr. Meyer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
300 Pasteur Dr
# MC5500
Palo Alto, CA 94305Phone+1 650-723-2300Fax+1 650-498-5840- Is this information wrong?
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 2010 - 2013
Stanford University School of MedicineClass of 2008
Certifications & Licensure
CA State Medical License 2009 - 2025- American Board of Internal Medicine Hematology
Clinical Trials
- Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders Start of enrollment: 2011 Mar 01
- Phase 1 Infused Donor T Regulatory Cells in Steroid Dependent/Refractory Chronic GVHD Start of enrollment: 2013 Jul 01
- Donor Regulatory T Cells in Treating Patients With Visceral Acute Graft-versus-Host Disease After Stem Cell Transplant Start of enrollment: 2015 Aug 06
- Join now to see all
Publications & Presentations
PubMed
- 30 citationsAlloantigen-specific type 1 regulatory T cells suppress through CTLA-4 and PD-1 pathways and persist long-term in patients.Pauline P. Chen, Alma-Martina Cepika, Rajni Agarwal-Hashmi, Gopin Saini, Molly Javier Uyeda, David M. Louis, Brandon Cieniewicz, Mansi Narula, Laura C. Amaya Hernandez...> ;Science Translational Medicine. 2021 Oct 27
- 5 citationsIdentification of Two Subsets of Murine DC1 Dendritic Cells That Differ by Surface Phenotype, Gene Expression, and Function.David Hongo, Pingping Zheng, Suparna Dutt, Rahul D. Pawar, Everett Meyer, Edgar G. Engleman, Samuel Strober> ;Frontiers in Immunology. 2021 Oct 26
- 27 citationsIncidence and risk factors associated with bleeding and thrombosis following chimeric antigen receptor T-cell therapyAndrew Johnsrud, Juliana Craig, John H. Baird, Jay Y. Spiegel, Lori Muffly, James L. Zehnder, John S. Tamaresis, Robert S. Negrin, Laura Johnston, Sally Arai, Judith A...> ;Blood Advances. 2021 Nov 9
- Join now to see all
Abstracts/Posters
- Phase I Trial Using CD19/CD22 Bispecific CAR T Cells in Pediatric and Adult Acute Lymphoblastic Leukemia (ALL)Everett H Meyer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Improved Outcomes for Relapsed/Refractory Classic Hodgkin Lymphoma Following Autologous Stem Cell Transplantation in the Era of Novel AgentsEverett H Meyer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
Immune Reconstitution with Orca-T Reveals ‘New Realm of Engineered Donor Grafts’ for Patients with Hematologic MalignanciesDecember 11th, 2022- Study Predicts Who May Benefit from CAR-T Cell Therapy for Blood CancersAugust 2nd, 2021
- First Clinical Data from Ongoing Orca-T Trial Shows Significantly Improved 12-Month Graft Versus Host Disease (GvHD)-Free and Relapse-Free Survival (GRFS) in Blood Cancer Patients Receiving a Hematopoietic Stem Cell Transplant (HSCT)December 6th, 2020
- Join now to see all
Hospital Affiliations
Stanford Health CarePalo Alto, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
